Cardiology
Cardiology CME
Earn Cardiology CME that fits how you practice. ReachMD offers practical, on-demand Cardiology CME/CE designed for cardiologists, fellows, APPs, and the full cardiovascular care team. Explore short, case-based activities and expert discussions across heart failure, interventional cardiology, electrophysiology, imaging, prevention, and more. Use this page to find your next activity fast. Browse learning tracks, jump into trending topics, or choose a series from our partner academies and clinical-practice resources. New activities are added regularly, so you can stay current with emerging evidence and evolving standards of care while earning credit on your schedule.
Start an activity below to earn credit or browse by topic to find the Cardiology CME most relevant to your practice.
1-15 of 176
- NEW EPISODE
Safety in oHCM Therapy: How and When to Transition Treatment?
MinuteCE®Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Owens, MD
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
CardiologyHypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
MinuteCE®Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
Michael Nassif, MD, MSc
Anjali Owens, MD
Molecular Precision: How Myosin Inhibitors Redefine Control
MinuteCE®Molecular Precision: How Myosin Inhibitors Redefine Control
Ahmad Masri, MD, MS
Anjali Owens, MD
Ahmad Masri, MD, MS
Michael Nassif, MD, MSc
Anjali Owens, MD
- advertisement
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
MinuteCE®When ß-Blockers Fall Short in oHCM: Time for a New Approach?
Ahmad Masri, MD, MS
Anjali Owens, MD
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CEBeyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD
Robert J. Mentz, MD, FHFSA, FACC
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Michael Nassif, MD, MSc
Anjali Owens, MD
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Ahmad Masri, MD, MS
Anjali Owens, MD
Cracking the Code of Obstruction: Unmet Needs in oHCM
MinuteCE®Cracking the Code of Obstruction: Unmet Needs in oHCM
Michael Nassif, MD, MSc
Patient Voices and Provider Partnerships to Advance Cardio-Kidney-Metabolic Outcomes
CME/CEPatient Voices and Provider Partnerships to Advance Cardio-Kidney-Metabolic Outcomes
Jay B. Wish, MD
- advertisement
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CECase-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
Prof. Dr. Johann Bauersachs
Javed Butler, MD
- MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
Javed Butler, MD
Prof. Dr. Johann Bauersachs
Carolyn S. P. Lam, MBBS, PhD
